Douglas E. Jorenby

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Douglas E. Jorenby · JAMA · 2006 · 1.7K citations

Medicine, Pharmacology, Pharmacotherapy +17

A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation

Douglas E. Jorenby, Scott J. Leischow, Mitchell Nides et al. · New England Journal of Medicine · 1999 · 1.6K citations · Full text

Public Health, Pharmacology, Pharmacotherapy +16

Gender differences in smoking cessation.

David W. Wetter, Susan L. Kenford, Stevens S. Smith et al. · Journal of Consulting and Clinical Psychology · 1999 · 400 citations

Public Health, Behavioral Sciences, Gender Studies +17

The Multiphase Optimization Strategy for Engineering Effective Tobacco Use Interventions

Linda M. Collins, Timothy B. Baker, Robin J. Mermelstein et al. · Annals of Behavioral Medicine · 2010 · 323 citations · Full text

Public Health, Health Behavior, Health Promotion +12

Development and validation of the Wisconsin Smoking Withdrawal Scale.

Samuel K. Welsch, Stevens S. Smith, David W. Wetter et al. · Experimental and Clinical Psychopharmacology · 1999 · 282 citations

Public Health, Health Behavior, Health Psychology +11